Related Experiment Videos
Regulatory T cells and autoimmune disease
1Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA, USA.
Immunological Reviews
|March 26, 2005
Summary
Regulatory T cells (Tregs) suppress autoreactivity by engaging B7 on effector T cells. This mechanism is crucial for controlling autoimmune diseases and maintaining immune tolerance.
Area of Science:
- Immunology
- Cell Biology
Background:
- Autoreactive T cells persist in the periphery despite central tolerance mechanisms.
- Regulatory T cells (Tregs) are a CD4(+)CD25(+) subpopulation implicated in suppressing autoreactivity.
Purpose of the Study:
- To review the role of cytokines and costimulatory molecules in Treg generation, maintenance, and function.
- To summarize Treg involvement in autoimmune diseases.
- To discuss the role of B7 on T-effector cells as a target for Treg-mediated suppression.
Main Methods:
- Literature review of Treg function and autoimmune disease involvement.
- Discussion of molecular mechanisms of Treg-mediated suppression, focusing on B7-CD28 interactions.
Main Results:
- Tregs play a critical role in controlling autoimmune diseases like type 1 diabetes, experimental autoimmune encephalomyelitis, and inflammatory bowel disease.
- B7 expressed on activated T-effector cells can serve as a target for Treg-dependent suppression.
- Engagement of B7 on effector T cells transmits inhibitory signals, attenuating effector T-cell function.
Conclusions:
- Tregs are vital for immune homeostasis and preventing autoimmunity.
- The B7-dependent suppression pathway offers a novel target for therapeutic intervention in autoimmune disorders.
- Further research is needed to fully elucidate the complex regulatory networks involving Tregs.